Cited by 286Protease and Inhibitor MechanismsTGF-β signaling in diseasesMechanisms of cancer metastasis

Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3

Open access
Baker, A H, George, S J, Zaltsman, A B, Murphy, G, Newby, A C·1999·British Journal of Cancer

Abstract

Dysregulation of matrix degrading metalloproteinase enzymes (MMPs) leads to increased extracellular matrix turnover, a key event in the local invasion and metastasis of many tumours. The tissue inhibitors of metalloproteinases (TIMPs) limit the activity of MMPs, which suggests their use in gene therapy. We have previously shown that overexpression of TIMP-1, -2 or -3 inhibits vascular smooth muscle and melanoma cell invasion, while TIMP-3 uniquely promotes apoptosis. We have therefore sought to determine whether TIMP-3 can inhibit invasion and promote apoptosis in other cancer cell types. Adenoviral-mediated overexpression of TIMP-3 inhibited invasion of HeLa and HT1080 cells through artificial basement membrane to similar levels as that achieved by TIMP-1 and -2. However, TIMP-3 uniquely promoted cell cycle entry and subsequent death by apoptosis. Apoptosis was confirmed by morphological analysis, terminal dUTP nick end labelling (TUNEL) and flow cytometry. The apoptotic phenotype was mimicked by addition of exogenous recombinant TIMP-3 to uninfected cultures demonstrating that the death signal is initiated extracellularly and that a bystander effect exists. These results show that TIMP-3 inhibits invasion in vitro and promotes apoptosis in cancer cell type of differing origin. This clearly identifies the potential of TIMP-3 for gene therapy of multiple cancer types.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6690217

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TIMP3 is a tissue inhibitor of MMPs that inhibits angiogenesis and tumor cell infiltration and also induces apoptosis.

    “TIMP3 is a tissue inhibitor of MMPs that inhibits angiogenesis and tumor cell infiltration and also induces apoptosis (2, 48).”

    From MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators (2008) · cites this paper as [2]

    The paper’s Summary (p. 1347) identifies TIMP-3 as a tissue inhibitor of metalloproteinases, and its discussion reports inhibited invasion of HeLa and HT1080 cancer cells and apoptotic death in three cancer cell lines. The copy does not report that TIMP-3 inhibits angiogenesis; searches for angiogenesis and blood-vessel formation found no supporting passage. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited by

Sorted by citations

Authors
Baker, A. H., George, S. J., Zaltsman, A. B., Murphy, G., & Newby, A. C.
Affiliations
  • Bristol Royal Infirmary (GB)
  • University of East Anglia (GB)
Venue
British Journal of Cancer
Published
1999-02-26
Volume
79
Issue
9-10
Pages
1347-1355
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2065084243
Cited by
286
References
0
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 3 · 2020: 8 · 2019: 9 · 2018: 3 · 2017: 3 · 2016: 9 · 2015: 7 · 2014: 8 · 2013: 10 · 2012: 12
FWCI
7.11
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords
TIMP-3, tissue inhibitors of metalloproteinases, tumor invasion, apoptosis, matrix metalloproteinases, extracellular matrix turnover, adenoviral gene therapy, HeLa cells, HT1080 cells, bystander effect, cell cycle entry, tumour metastasis
MeSH terms
Adenoviridae, Bromodeoxyuridine, Cell Cycle, Collagen, DNA, Drug Combinations, Genetic Vectors, HeLa Cells, Humans, Laminin, Neoplasm Invasiveness, Proteoglycans, Transfection, Tumor Cells, Cultured, Apoptosis, Tissue Inhibitor of Metalloproteinase-3, In Situ Nick-End Labeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review